These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11406878)

  • 1. Transdermal fentanyl in the hospice: a survey of rescue dosing and pain control.
    Robards M
    Am J Hosp Palliat Care; 2001; 18(1):47-50. PubMed ID: 11406878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breakthrough strong opioid analgesia prescription in patients using transdermal fentanyl admitted to a hospice.
    Lawrie I; Lloyd-Williams M; Waterhouse E
    Am J Hosp Palliat Care; 2003; 20(3):229-30. PubMed ID: 12785045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From codeine to transdermal fentanyl for cancer pain control: a safety and efficacy clinical trial.
    Mystakidou K; Befon S; Kouskouni E; Gerolymatos K; Georgaki S; Tsilika E; Vlahos L
    Anticancer Res; 2001; 21(3C):2225-30. PubMed ID: 11501851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inappropriate use of high doses of transdermal fentanyl at admission to a palliative care unit.
    Botterman J; Criel N
    Palliat Med; 2011 Mar; 25(2):111-6. PubMed ID: 20937611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
    Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
    Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Three-day-type transdermal fentanyl patch conversion by rapid titration method with short-acting oral oxycodone for cancer pain].
    Yamazaki K; Fujio N; Ishikawa N; Watanabe H; Kameyama M
    Gan To Kagaku Ryoho; 2012 Mar; 39(3):405-8. PubMed ID: 22421768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study.
    Sittl R; Nuijten M; Nautrup BP
    Clin Ther; 2005 Jul; 27(7):1022-31. PubMed ID: 16154481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal fentanyl for the management of cancer pain: a survey of 1005 patients.
    Radbruch L; Sabatowski R; Petzke F; Brunsch-Radbruch A; Grond S; Lehmann KA
    Palliat Med; 2001 Jul; 15(4):309-21. PubMed ID: 12054148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-titration, multicenter study of oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients using transdermal fentanyl for persistent pain.
    Christie JM; Simmonds M; Patt R; Coluzzi P; Busch MA; Nordbrock E; Portenoy RK
    J Clin Oncol; 1998 Oct; 16(10):3238-45. PubMed ID: 9779697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
    Sittl R; Likar R; Nautrup BP
    Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.
    Mitra F; Chowdhury S; Shelley M; Williams G
    Pain Med; 2013 Jan; 14(1):75-83. PubMed ID: 23320402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.
    Tawfik MO; Bryuzgin V; Kourteva G;
    Curr Med Res Opin; 2004 Mar; 20(3):259-67. PubMed ID: 15025835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dosing frequency of sustained-release opioids and the prevalence of end-of-dose failure in cancer pain control: a Korean multicenter study.
    Kim DY; Song HS; Ahn JS; Ryoo BY; Shin DB; Yim CY; Kim SY
    Support Care Cancer; 2010 Feb; 19(2):297-301. PubMed ID: 20213238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of a six-hour continuous overlap method for converting intravenous to transdermal fentanyl in cancer pain.
    Samala RV; Bloise R; Davis MP
    J Pain Symptom Manage; 2014 Jul; 48(1):132-6. PubMed ID: 24291296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine.
    Radbruch L; Sabatowski R; Loick G; Kulbe C; Kasper M; Grond S; Lehmann KA
    Palliat Med; 2000 Mar; 14(2):111-9. PubMed ID: 10829145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A safe and effective method for converting patients from transdermal to intravenous fentanyl for the treatment of acute cancer-related pain.
    Kornick CA; Santiago-Palma J; Schulman G; O'Brien PC; Weigand S; Payne R; Manfredi PL
    Cancer; 2003 Jun; 97(12):3121-4. PubMed ID: 12784350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved cancer pain treatment using combined fentanyl-TTS and tramadol.
    Marinangeli F; Ciccozzi A; Aloisio L; Colangeli A; Paladini A; Bajocco C; Coaccioli S; Varrassi G
    Pain Pract; 2007 Dec; 7(4):307-12. PubMed ID: 17986161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with transdermal and orally administered opioids in palliative care patients--a retrospective study.
    Clemens KE; Klaschik E
    Jpn J Clin Oncol; 2007 Apr; 37(4):302-9. PubMed ID: 17519302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alternative algorithm for dosing transdermal fentanyl for cancer-related pain.
    Breitbart W; Chandler S; Eagel B; Ellison N; Enck RE; Lefkowitz M; Payne R
    Oncology (Williston Park); 2000 May; 14(5):695-705; discussion 705, 709-17. PubMed ID: 10853461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.